Chlorzoxazone (BioDeep_00000001857)

 

Secondary id: BioDeep_00000408943

human metabolite blood metabolite


代谢物信息卡片


5-chloro-2,3-dihydro-1,3-benzoxazol-2-one

化学式: C7H4ClNO2 (168.9931)
中文名称: 氯唑沙宗
谱图信息: 最多检出来源 Homo sapiens(blood) 51.33%

分子结构信息

SMILES: C1=CC2=C(C=C1Cl)NC(=O)O2
InChI: InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)

描述信息

A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BB - Oxazol, thiazine, and triazine derivatives
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
D002491 - Central Nervous System Agents
COVID info from PDB, Protein Data Bank
Corona-virus
KEIO_ID C042
Coronavirus
SARS-CoV-2
COVID-19
SARS-CoV
COVID19
SARS2
SARS

同义名列表

22 个代谢物同义名

5-chloro-2,3-dihydro-1,3-benzoxazol-2-one; McNeil brand OF chlorzoxazone; 5-Chloro-2-hydroxybenzoxazole; 2-Hydroxy-5-chlorobenzoxazole; 5-Chloro-2(3H)-benzoxazolone; Ortho brand OF chlorzoxazone; 5-Chloro-2-benzoxazolinone; 5-Chlorobenzoxazolin-2-one; 5-Chloro-2-benzoxazolone; 5-Chlorobenzoxazolidone; 5-Chloro-2-benzoxazolol; Parafon forte DSC; Chlorzoxazonum; Chlorzoxazona; chlorzoxazone; Chlorzoxazon; Chloroxazone; Chlorzoxane; Paraflex; Parafon; Chlorzoxazone; Chlorzoxazone



数据库引用编号

24 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(1)

PlantCyc(0)

代谢反应

1 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(1)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 11 ATXN2, CYP1A1, CYP2A6, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, NAT2
Peripheral membrane protein 4 CYP1A1, CYP1B1, CYP2B6, CYP2E1
Endoplasmic reticulum membrane 12 CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5
Nucleus 1 NAT2
cytosol 3 ATXN2, GPT, NAT2
trans-Golgi network 1 ATXN2
Cell membrane 1 NAT2
Multi-pass membrane protein 3 MT-CYB, NAT2, SLC45A2
Golgi apparatus 1 ATXN2
Golgi membrane 1 INS
mitochondrial inner membrane 3 CYP1A1, CYP2E1, MT-CYB
neuronal cell body 1 NAT2
plasma membrane 4 CYP2C19, CYP2C8, CYP2C9, NAT2
Membrane 9 ATXN2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, CYP3A5, MT-CYB, NAT2, SLC45A2
axon 1 NAT2
basolateral plasma membrane 1 NAT2
extracellular exosome 3 GPT, NAT2, SPINK1
endoplasmic reticulum 1 CYP2D6
extracellular space 2 IL6, INS
perinuclear region of cytoplasm 1 ATXN2
mitochondrion 4 CYP1A1, CYP1B1, CYP2D6, MT-CYB
intracellular membrane-bounded organelle 12 CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5
Microsome membrane 9 CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5
Secreted 3 IL6, INS, SPINK1
extracellular region 2 IL6, INS
Single-pass membrane protein 1 CYP2D6
transcription regulator complex 1 NAT2
Melanosome membrane 1 SLC45A2
Mitochondrion inner membrane 3 CYP1A1, CYP2E1, MT-CYB
endosome lumen 1 INS
cytoplasmic stress granule 1 ATXN2
secretory granule lumen 1 INS
Golgi lumen 1 INS
endoplasmic reticulum lumen 2 IL6, INS
transport vesicle 1 INS
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 INS
respiratory chain complex III 1 MT-CYB
ribonucleoprotein complex 1 ATXN2
cytoplasmic microtubule 1 CYP2A6
external side of apical plasma membrane 1 NAT2
interleukin-6 receptor complex 1 IL6
NatA complex 1 NAT2


文献列表

  • Hui-Lin Yang, Ying Li, Yi Chen, Si-Ying Chen, Yue-Ting Li, Yong Huang, Lin Zheng, Jing Huang, Yong-Lin Wang, Zi-Peng Gong. [Effect of Laportea bulbifera extract on CYP450 enzyme activities in rats by Cocktail probe drug method]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2022 Dec; 47(23):6320-6332. doi: 10.19540/j.cnki.cjcmm.20220623.204. [PMID: 36604876]
  • Shosei Kano, Hiroshi Takahashi. Cholesterol's inhibition effect on entering of chlorzoxazone into phosphatidylethanolamine bilayer: Relevance to cytochrome P450 drug metabolism at endoplasmic reticulum membranes. Biochimica et biophysica acta. Biomembranes. 2022 09; 1864(9):183954. doi: 10.1016/j.bbamem.2022.183954. [PMID: 35523303]
  • Shipra Bhatt, Vinay Kumar, Ashish Dogra, Probir Kumar Ojha, Priya Wazir, Payare Lal Sangwan, Gurdarshan Singh, Utpal Nandi. Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor. Xenobiotica; the fate of foreign compounds in biological systems. 2021 Jun; 51(6):625-635. doi: 10.1080/00498254.2021.1883769. [PMID: 33539218]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Sayed I M Zayed, Yousry M Issa. Differential Pulse Anodic Voltammetric Determination of Chlorzoxazone in Pharmaceutical Formulation using Carbon Paste Electrode. Acta chimica Slovenica. 2020 Dec; 67(4):1053-1060. doi: 10.17344/acsi.2020.5731. [PMID: 33533475]
  • Li Tang, Xiao-Hui Gao, Bei Zhao, Jie-Ran Luo, Xin-Yang Shi, Rui Ge, Shu-Rong Ban, Qing-Shan Li. Design and synthesis of new disubstituted benzoxazolone derivatives that act as iNOS inhibitors with potent anti-inflammatory activity against LPS-induced acute lung injury (ALI). Bioorganic & medicinal chemistry. 2020 11; 28(21):115733. doi: 10.1016/j.bmc.2020.115733. [PMID: 33065432]
  • Xiaofei Du, Joao L Carvalho-de-Souza, Cenfu Wei, Willy Carrasquel-Ursulaez, Yenisleidy Lorenzo, Naileth Gonzalez, Tomoya Kubota, Julia Staisch, Timothy Hain, Natalie Petrossian, Michael Xu, Ramon Latorre, Francisco Bezanilla, Christopher M Gomez. Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proceedings of the National Academy of Sciences of the United States of America. 2020 03; 117(11):6023-6034. doi: 10.1073/pnas.1920008117. [PMID: 32132200]
  • Luchan Deng, Hongling Li, Xiaodong Su, Yingjie Zhang, Haoying Xu, Linyuan Fan, Junfen Fan, Qin Han, Xueyuan Bai, Robert Chunhua Zhao. Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation. Cell death & disease. 2020 03; 11(3):158. doi: 10.1038/s41419-020-2357-8. [PMID: 32123161]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Hsien-Tsung Yao, Jia-Hsuan Lin, Yun-Ta Liu, Mei-Ling Li, Wenchang Chiang. Food-Drug Interaction between the Adlay Bran Oil and Drugs in Rats. Nutrients. 2019 Oct; 11(10):. doi: 10.3390/nu11102473. [PMID: 31618937]
  • Sebastian Trousil, Patrizia Lee, Robert J Edwards, Lynn Maslen, Jingky P Lozan-Kuehne, Ramya Ramaswami, Eric O Aboagye, Stephen Clarke, Christopher Liddle, Rohini Sharma. Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation. British journal of pharmacology. 2019 09; 176(18):3712-3722. doi: 10.1111/bph.14776. [PMID: 31236938]
  • Jiake He, Ning Li, Jiaqiu Xu, Jing Zhu, Yang Yu, Xijing Chen, Yang Lu. An LC-MS/MS Validated Method for Quantification of Chlorzoxazone in Human Plasma and Its Application to a Bioequivalence Study. Journal of chromatographic science. 2019 Aug; 57(8):751-757. doi: 10.1093/chromsci/bmz052. [PMID: 31363741]
  • Nicolas Quesnot, Simon Bucher, Christina Gade, Manuel Vlach, Elise Vene, Samuel Valença, Thomas Gicquel, Helle Holst, Marie-Anne Robin, Pascal Loyer. Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes. Archives of toxicology. 2018 10; 92(10):3077-3091. doi: 10.1007/s00204-018-2300-2. [PMID: 30151596]
  • C Gade, K Dalhoff, T S Petersen, T Riis, C Schmeltz, E Chabanova, H R Christensen, G Mikus, J Burhenne, J C Holm, H Holst. Higher chlorzoxazone clearance in obese children compared with nonobese peers. British journal of clinical pharmacology. 2018 08; 84(8):1738-1747. doi: 10.1111/bcp.13602. [PMID: 29618168]
  • Dalia Mohamed, Maha A Hegazy, Mona S Elshahed, Safaa S Toubar, Marwa I Helmy. Liquid chromatography-tandem MS/MS method for simultaneous quantification of paracetamol, chlorzoxazone and aceclofenac in human plasma: An application to a clinical pharmacokinetic study. Biomedical chromatography : BMC. 2018 Jul; 32(7):e4232. doi: 10.1002/bmc.4232. [PMID: 29505100]
  • Eun Chae Gong, Satya Chea, Anand Balupuri, Nam Sook Kang, Young-Won Chin, Young Hee Choi. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone. Molecules (Basel, Switzerland). 2018 Mar; 23(3):. doi: 10.3390/molecules23030555. [PMID: 29498658]
  • Yen-Ping Lin, Ying-Lin Lee, Chien-Ya Hung, Chuan-Fa Chang, Yi Chen. Detection of adulterated drugs in traditional Chinese medicine and dietary supplements using hydrogen as a carrier gas. PloS one. 2018; 13(10):e0205371. doi: 10.1371/journal.pone.0205371. [PMID: 30304050]
  • Satish Kumar Bedada, Prasad Neerati. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. European journal of clinical pharmacology. 2018 Jan; 74(1):91-97. doi: 10.1007/s00228-017-2345-9. [PMID: 28983678]
  • Satish Kumar Bedada, Praveen Kumar Boga. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers. Xenobiotica; the fate of foreign compounds in biological systems. 2017 Dec; 47(12):1035-1041. doi: 10.1080/00498254.2016.1241450. [PMID: 27670974]
  • Jia Sun, Yuan Lu, Yueting Li, Jie Pan, Chunhua Liu, Zipeng Gong, Jing Huang, Jiang Zheng, Lin Zheng, Yongjun Li, Ting Liu, Yonglin Wang. Influence of Shenxiong Glucose Injection on the Activities of Six CYP Isozymes and Metabolism of Warfarin in Rats Assessed Using Probe Cocktail and Pharmacokinetic Approaches. Molecules (Basel, Switzerland). 2017 Nov; 22(11):. doi: 10.3390/molecules22111994. [PMID: 29156621]
  • Nan Hu, Yanjuan Huang, Xuejiao Gao, Sai Li, Zhixiang Yan, Bin Wei, Ru Yan. Effects of dextran sulfate sodium induced experimental colitis on cytochrome P450 activities in rat liver, kidney and intestine. Chemico-biological interactions. 2017 Jun; 271(?):48-58. doi: 10.1016/j.cbi.2017.04.018. [PMID: 28438436]
  • Shu-fen He, Wen-zheng Ju, Hao-bin Hu, Li-jing Zhu, Qian Zhang, Guo-liang Dai. [Change of hepatic drug metabolism enzymes in rat depression model with kidney-yang deficiency]. Yao xue xue bao = Acta pharmaceutica Sinica. 2017 Feb; 52(2):258-63. doi: . [PMID: 29979512]
  • Min Xu, Huaqiao Tang, Qian Rong, Yuanli Zhang, Yinglun Li, Ling Zhao, Gang Ye, Fei Shi, Cheng Lv. The Effects of Formaldehyde on Cytochrome P450 Isoform Activity in Rats. BioMed research international. 2017; 2017(?):6525474. doi: 10.1155/2017/6525474. [PMID: 28555194]
  • Rachumallu Ramakrishna, Manisha Bhateria, Rajbir Singh, Rabi Sankar Bhatta. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes. The Journal of steroid biochemistry and molecular biology. 2016 10; 163(?):183-92. doi: 10.1016/j.jsbmb.2016.05.018. [PMID: 27224941]
  • Lukas Witt, Yosuke Suzuki, Nicolas Hohmann, Gerd Mikus, Walter E Haefeli, Jürgen Burhenne. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2016 Aug; 1027(?):207-13. doi: 10.1016/j.jchromb.2016.05.049. [PMID: 27300008]
  • Ayumi Yamada, Nobutaka Shimizu, Takaaki Hikima, Masaki Takata, Toshihide Kobayashi, Hiroshi Takahashi. Effect of Cholesterol on the Interaction of Cytochrome P450 Substrate Drug Chlorzoxazone with the Phosphatidylcholine Bilayer. Biochemistry. 2016 07; 55(28):3888-98. doi: 10.1021/acs.biochem.6b00286. [PMID: 27347790]
  • Christina Gade, Gerd Mikus, Hanne Rolighed Christensen, Kim Peder Dalhoff, Jens-Christian Holm, Helle Holst. The CYTONOX trial. Danish medical journal. 2016 May; 63(5):. doi: . [PMID: 27127017]
  • Satish Kumar Bedada, Prasad Neerati. Resveratrol Pretreatment Affects CYP2E1 Activity of Chlorzoxazone in Healthy Human Volunteers. Phytotherapy research : PTR. 2016 Mar; 30(3):463-8. doi: 10.1002/ptr.5549. [PMID: 26680654]
  • Anaïs Michaut, Dounia Le Guillou, Caroline Moreau, Simon Bucher, Mitchell R McGill, Sophie Martinais, Thomas Gicquel, Isabelle Morel, Marie-Anne Robin, Hartmut Jaeschke, Bernard Fromenty. A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen. Toxicology and applied pharmacology. 2016 Feb; 292(?):40-55. doi: 10.1016/j.taap.2015.12.020. [PMID: 26739624]
  • Yu-xin Zang, Bing-ting Sun, Wen-zhu Zhao, Na Rong, Guo-liang Dai, Wen-zheng Ju, Heng-shan Tan. [Study of change in activity of hepatic drug metabolism enzymes in rat model of chronic unpredictable mild stress]. Yao xue xue bao = Acta pharmaceutica Sinica. 2015 Mar; 50(3):319-25. doi: . [PMID: 26118111]
  • Lin Zheng, Yuan Lu, Xu Cao, Yong Huang, Yue Liu, Li Tang, Shang-Gao Liao, Ai-Min Wang, Yong-Jun Li, Yan-Yu Lan, Yong-Lin Wang. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs. Journal of ethnopharmacology. 2014 Dec; 158 Pt A(?):276-82. doi: 10.1016/j.jep.2014.10.031. [PMID: 25446640]
  • Zhi-Qiang Chang, Jian Li, Qian-Qian Zhai. Evaluation on activity of cytochrome p450 enzymes in turbot via a probe drug cocktail. Journal of aquatic animal health. 2014 Dec; 26(4):272-7. doi: 10.1080/08997659.2014.938868. [PMID: 25369285]
  • Astrid Jordet Langhammer, Odd Georg Nilsen. Fennel and raspberry leaf as possible inhibitors of acetaminophen oxidation. Phytotherapy research : PTR. 2014 Oct; 28(10):1573-6. doi: 10.1002/ptr.5124. [PMID: 24458977]
  • Baolian Wang, Shuang Yang, Jinping Hu, Yan Li. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. Journal of ethnopharmacology. 2014 Sep; 155(3):1473-82. doi: 10.1016/j.jep.2014.07.026. [PMID: 25091466]
  • Dong-Lou Liang, Shuang-Li Zheng. Effects of icaritin on cytochrome P450 enzymes in rats. Die Pharmazie. 2014 Apr; 69(4):301-5. doi: NULL. [PMID: 24791596]
  • Qin Li, Ying Liu, Jianjie Jiao, Caili Zhang, Jianshi Lou. Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach. Drug development and industrial pharmacy. 2014 Feb; 40(2):157-62. doi: 10.3109/03639045.2012.752499. [PMID: 23339682]
  • Yi Huang, Shuang-li Zheng, Hai-yan Zhu, Zhi-sheng Xu, Ren-ai Xu. Effects of aescin on cytochrome P450 enzymes in rats. Journal of ethnopharmacology. 2014; 151(1):583-90. doi: 10.1016/j.jep.2013.11.016. [PMID: 24252494]
  • Jian-Long Chen, Yu-Ling Zhang, Yu Dong, Ji-Yu Gong, Han-Ming Cui. [CYP450 enzyme inhibition of berberine in pooled human liver microsomes by cocktail probe drugs]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2013 Jun; 38(12):2009-14. doi: . [PMID: 24066602]
  • Tao Su, Chunqin Mao, Fangzhou Yin, Zhiling Yu, Ying Lin, Yu Song, Tulin Lu. Effects of unprocessed versus vinegar-processed Schisandra chinensis on the activity and mRNA expression of CYP1A2, CYP2E1 and CYP3A4 enzymes in rats. Journal of ethnopharmacology. 2013 Apr; 146(3):734-43. doi: 10.1016/j.jep.2013.01.028. [PMID: 23376044]
  • Wensi Lin, Jianmei Zhang, Xiaomei Ling, Ning Yu, Jing Li, Haisong Yang, Runtao Li, Jingrong Cui. Evaluation of the effect of TM208 on the activity of five cytochrome P450 enzymes using on-line solid-phase extraction HPLC-DAD: a cocktail approach. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2013 Apr; 923-924(?):29-36. doi: 10.1016/j.jchromb.2013.01.031. [PMID: 23466445]
  • Markéta Paloncýová, Karel Berka, Michal Otyepka. Molecular insight into affinities of drugs and their metabolites to lipid bilayers. The journal of physical chemistry. B. 2013 Feb; 117(8):2403-10. doi: 10.1021/jp311802x. [PMID: 23387302]
  • Jingwen Gao, Zhan Shi, Shuzhen Zhu, George Q Li, Ru Yan, Meicun Yao. Influences of processed rhubarbs on the activities of four CYP isozymes and the metabolism of saxagliptin in rats based on probe cocktail and pharmacokinetics approaches. Journal of ethnopharmacology. 2013 Jan; 145(2):566-72. doi: 10.1016/j.jep.2012.11.030. [PMID: 23207062]
  • Mi Hye Kwon, Cheol Jung Lee, Yong Yeon Cho, Hee Eun Kang. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2013; 16(4):648-56. doi: 10.18433/j3dw3s. [PMID: 24210069]
  • Na Gao, Dan Zou, Hai-Ling Qiao. Concentration-dependent inhibitory effect of Baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in vitro and in vivo. PloS one. 2013; 8(1):e53038. doi: 10.1371/journal.pone.0053038. [PMID: 23301016]
  • Octavio Jiménez-Garza, Sergio Márquez-Gamiño, Arnulfo Albores, Cipriana Caudillo-Cisneros, Mariella Carrieri, Giovanni Battista Bartolucci, Maurizio Manno. CYP2E1 phenotype in Mexican workers occupationally exposed to low levels of toluene. Toxicology letters. 2012 Apr; 210(2):254-63. doi: 10.1016/j.toxlet.2012.01.021. [PMID: 22342293]
  • Yong-Long Han, Dan Li, Bin Ren, Guang-Ping Jing, Xiang-Le Meng, Zhi-Yong Zhou, Qi Yu, Yan Li, Li-Li Wan, Cheng Guo. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. Journal of ethnopharmacology. 2012 Jan; 139(1):104-9. doi: 10.1016/j.jep.2011.10.019. [PMID: 22079696]
  • Pius S Fasinu, Patrick J Bouic, Bernd Rosenkranz. An overview of the evidence and mechanisms of herb-drug interactions. Frontiers in pharmacology. 2012; 3(?):69. doi: 10.3389/fphar.2012.00069. [PMID: 22557968]
  • Izumi Yamasaki, Masayoshi Yamada, Nobuo Uotsu, Sachiyuki Teramoto, Risa Takayanagi, Yasuhiko Yamada. Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats. Biomedical research (Tokyo, Japan). 2012; 33(4):235-42. doi: 10.2220/biomedres.33.235. [PMID: 22975634]
  • Arthur I Cederbaum, Lili Yang, Xiaodong Wang, Defeng Wu. CYP2E1 Sensitizes the Liver to LPS- and TNF α-Induced Toxicity via Elevated Oxidative and Nitrosative Stress and Activation of ASK-1 and JNK Mitogen-Activated Kinases. International journal of hepatology. 2012; 2012(?):582790. doi: 10.1155/2012/582790. [PMID: 22028977]
  • Imam H Shaik, Reza Mehvar. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats. Journal of pharmaceutical sciences. 2011 Dec; 100(12):5281-92. doi: 10.1002/jps.22708. [PMID: 21780121]
  • Cyrus Ghobadi, Trevor N Johnson, Mohsen Aarabi, Lisa M Almond, Aurel Constant Allabi, Karen Rowland-Yeo, Masoud Jamei, Amin Rostami-Hodjegan. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. Clinical pharmacokinetics. 2011 Dec; 50(12):809-22. doi: 10.2165/11594420-000000000-00000. [PMID: 22087867]
  • Katsunori Yamaura, Maki Shimada, Noriyuki Nakayama, Koichi Ueno. Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats. Pharmacognosy research. 2011 Oct; 3(4):250-5. doi: 10.4103/0974-8490.89745. [PMID: 22224048]
  • H W Lee, D W Kim, P B Phapale, M-S Lim, J Park, J J Seo, K M Park, Y-K Park, Y-R Yoon. In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms. Journal of clinical pharmacy and therapeutics. 2011 Aug; 36(4):496-503. doi: 10.1111/j.1365-2710.2010.01201.x. [PMID: 21729114]
  • A M Dolga, N Terpolilli, F Kepura, I M Nijholt, H-G Knaus, B D'Orsi, J H M Prehn, U L M Eisel, T Plant, N Plesnila, C Culmsee. KCa2 channels activation prevents [Ca2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia. Cell death & disease. 2011 Apr; 2(?):e147. doi: 10.1038/cddis.2011.30. [PMID: 21509037]
  • Nicolas A Stewart, Shama C Buch, Thomas P Conrads, Robert A Branch. A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution. The Analyst. 2011 Feb; 136(3):605-12. doi: 10.1039/c0an00643b. [PMID: 21107456]
  • Khaled M Elokely, Mohamed A Eldawy, Mohamed A Elkersh, Tarek F El-Moselhy. Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N-Methylnicotinamide Chloride as a Fluorogenic Agent. International journal of analytical chemistry. 2011; 2011(?):840178. doi: 10.1155/2011/840178. [PMID: 21647288]
  • Hiroshi Yamazaki, Kana Horiuchi, Ryohji Takano, Taku Nagano, Makiko Shimizu, Masato Kitajima, Norie Murayama, Fumiaki Shono. Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling. International journal of environmental research and public health. 2010 09; 7(9):3406-21. doi: 10.3390/ijerph7093406. [PMID: 20948932]
  • P Wiercinska, E J Squires. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5. Drug metabolism and disposition: the biological fate of chemicals. 2010 May; 38(5):857-62. doi: 10.1124/dmd.109.030528. [PMID: 20164110]
  • Chun-hua Xia, Jian-guo Sun, Guang-ji Wang, Li-li Shang, Xiao-xuan Zhang, Rong Zhang, Ying Peng, Xiao-jin Wang, Hai-ping Hao, Lin Xie, Michael S Roberts. Herb-drug interactions: in vivo and in vitro effect of Shenmai injection, a herbal preparation, on the metabolic activities of hepatic cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in rats. Planta medica. 2010 Feb; 76(3):245-50. doi: 10.1055/s-0029-1186082. [PMID: 19774504]
  • Hubert W Vesper, Samuel P Caudill, John D Osterloh, Tunde Meyers, Deanna Scott, Gary L Myers. Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004. Environmental health perspectives. 2010 Feb; 118(2):278-83. doi: 10.1289/ehp.0901021. [PMID: 20123601]
  • P Piccoli, M Carrieri, L Padovano, M Di Mare, G B Bartolucci, M E Fracasso, J S Lepera, M Manno. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene. Toxicology letters. 2010 Jan; 192(1):29-33. doi: 10.1016/j.toxlet.2009.10.023. [PMID: 19900514]
  • Hye Y Jung, Hee E Kang, Young H Choi, So H Kim, Myung G Lee. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels. Biopharmaceutics & drug disposition. 2009 Nov; 30(8):485-93. doi: 10.1002/bdd.685. [PMID: 19753555]
  • SoJeong Yi, Joo-Youn Cho, Kyoung Soo Lim, Kyu-pyo Kim, Jaewoo Kim, Bo-Hyung Kim, Jang-hee Hong, In-Jin Jang, Sang-Goo Shin, Kyung-Sang Yu. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers. Basic & clinical pharmacology & toxicology. 2009 Oct; 105(4):249-56. doi: 10.1111/j.1742-7843.2009.00423.x. [PMID: 19422358]
  • Hai Jia, Aixia Xu, Jiyong Yuan, Xiang Gao, Jun Gao. [Experimental study on cytochrome P450 enzymes after receiving ferment powder caterpillar fungus]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2009 Aug; 34(16):2079-82. doi: . [PMID: 19938551]
  • A I Hubich, F A Lakhvich, M V Sholukh. The mechanism of the rat liver cytochrome P4502E1 inhibition by the synthetic prostanoids of A-type. Prostaglandins & other lipid mediators. 2009 Jun; 89(1-2):16-9. doi: 10.1016/j.prostaglandins.2009.02.003. [PMID: 19464662]
  • Ahmed Z Abdel-Azeem, Atef A Abdel-Hafez, Gamal S El-Karamany, Hassan H Farag. Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies. Bioorganic & medicinal chemistry. 2009 May; 17(10):3665-70. doi: 10.1016/j.bmc.2009.03.065. [PMID: 19398345]
  • Hyung-Ryong Kim, Geum-Hwa Lee, Eun Yi Cho, Soo-Wan Chae, Taeho Ahn, Han-Jung Chae. Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1. Journal of cell science. 2009 Apr; 122(Pt 8):1126-33. doi: 10.1242/jcs.038430. [PMID: 19339548]
  • Ying Liu, Jianjie Jiao, Caili Zhang, Jianshi Lou. A simplified method to determine five cytochrome p450 probe drugs by HPLC in a single run. Biological & pharmaceutical bulletin. 2009 Apr; 32(4):717-20. doi: 10.1248/bpb.32.717. [PMID: 19336911]
  • Robert D Finn, Colin J Henderson, Claire L Scott, C Roland Wolf. Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway. The Biochemical journal. 2009 Jan; 417(1):43-54. doi: 10.1042/bj20080740. [PMID: 18778245]
  • Angelo A Izzo, Edzard Ernst. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009; 69(13):1777-98. doi: 10.2165/11317010-000000000-00000. [PMID: 19719333]
  • Aleksanteri Petsalo, Miia Turpeinen, Olavi Pelkonen, Ari Tolonen. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column. Journal of chromatography. A. 2008 Dec; 1215(1-2):107-15. doi: 10.1016/j.chroma.2008.10.122. [PMID: 19019380]
  • Robert D Finn, Lesley A McLaughlin, Sebastien Ronseaux, Ian Rosewell, J Brian Houston, Colin J Henderson, C Roland Wolf. Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. The Journal of biological chemistry. 2008 Nov; 283(46):31385-93. doi: 10.1074/jbc.m803496200. [PMID: 18805792]
  • M I Díaz Gómez, S L Fanelli, A M A Delgado de Layño, F M Bietto, J A Castro, G D Castro. Deleterious effects induced by oxidative stress in liver nuclei from rats receiving an alcohol-containing liquid diet. Toxicology and industrial health. 2008 Nov; 24(10):625-34. doi: 10.1177/0748233708101207. [PMID: 19141567]
  • Chun-hua Wu, Xia Wang, Li-xing Zheng. [HPLC for determination of activity of serum CYP2E1]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases. 2008 Aug; 26(8):496-7. doi: NULL. [PMID: 19358769]
  • Choong Y Ahn, Soo K Bae, Young S Jung, Inchul Lee, Young C Kim, Myung G Lee, Wan G Shin. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1233-41. doi: 10.1124/dmd.107.017442. [PMID: 18378564]
  • Hao Tang, Guangtao Min, Bin Ge, Yumin Li, Xia Liu, Shengxiang Jiang. Evaluation of protective effects of Chi-Zhi-Huang decoction on Phase I drug metabolism of liver injured rats by cocktail probe drugs. Journal of ethnopharmacology. 2008 May; 117(3):420-6. doi: 10.1016/j.jep.2008.02.020. [PMID: 18403144]
  • Nantaporn Prompila, Supeecha Wittayalertpanya, Piyawat Komolmit. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2008 May; 91(5):733-8. doi: . [PMID: 18672640]
  • N Ma, W-Y Liu, H-D Li, X-Y Jiang, W Liu, X Liu, C-F Deng, B-K Zhang, D-X Xiang. High-performance liquid chromatographic analysis of resveratrol analog 3,5,4'-trimethoxystilbene in rat plasma. Methods and findings in experimental and clinical pharmacology. 2008 Apr; 30(3):215-20. doi: 10.1358/mf.2008.30.3.1139052. [PMID: 18597006]
  • I Rodeiro, M T Donato, A Lahoz, J A González-Lavaut, A Laguna, J V Castell, R Delgado, M J Gómez-Lechón. Modulation of P450 enzymes by Cuban natural products rich in polyphenolic compounds in rat hepatocytes. Chemico-biological interactions. 2008 Mar; 172(1):1-10. doi: 10.1016/j.cbi.2007.10.004. [PMID: 18053976]
  • K Rajnarayana, A Venkatesham, M Nagulu, M Srinivas, D R Krishna. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers. Drug metabolism and drug interactions. 2008; 23(3-4):311-21. doi: 10.1515/dmdi.2008.23.3-4.311. [PMID: 19326774]
  • A Mary Vilay, Mariann D Churchwell, Bruce A Mueller. Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. Critical care (London, England). 2008; 12(6):235. doi: 10.1186/cc7093. [PMID: 19040780]
  • Xiao Xu, Hai-Yan Liu, Li Liu, Lin Xie, Xiao-Dong Liu. The influence of a newly developed quinolone: antofloxacin, on CYP activity in rats. European journal of drug metabolism and pharmacokinetics. 2008 Jan; 33(1):1-7. doi: 10.1007/bf03191012. [PMID: 18543578]
  • Phisit Khemawoot, Kousuke Nishino, Junko Ishizaki, Koichi Yokogawa, Ken-ichi Miyamoto. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats. European journal of pharmacology. 2007 Nov; 574(1):71-6. doi: 10.1016/j.ejphar.2007.06.032. [PMID: 17651723]
  • Su N Kim, Ji Y Seo, Da W Jung, Min Y Lee, Young S Jung, Young C Kim. Induction of hepatic CYP2E1 by a subtoxic dose of acetaminophen in rats: increase in dichloromethane metabolism and carboxyhemoglobin elevation. Drug metabolism and disposition: the biological fate of chemicals. 2007 Oct; 35(10):1754-8. doi: 10.1124/dmd.107.015545. [PMID: 17620348]
  • P Venkatesh, T Harisudhan, Hira Choudhury, Ramesh Mullangi, Nuggehally R Srinivas. Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing. European journal of drug metabolism and pharmacokinetics. 2007 Oct; 32(4):189-96. doi: 10.1007/bf03191003. [PMID: 18348467]
  • Xin Wang, Xuan Zhao, Dan Li, Ya-Qing Lou, Zhi-Bin Lin, Guo-Liang Zhang. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biological & pharmaceutical bulletin. 2007 Sep; 30(9):1702-6. doi: 10.1248/bpb.30.1702. [PMID: 17827724]
  • Lawrence H Lash, David A Putt, Paul Huang, Sarah E Hueni, Jean C Parker. Modulation of hepatic and renal metabolism and toxicity of trichloroethylene and perchloroethylene by alterations in status of cytochrome P450 and glutathione. Toxicology. 2007 Jun; 235(1-2):11-26. doi: 10.1016/j.tox.2007.03.001. [PMID: 17433522]
  • Lena Ernstgård, Gunnar Johanson, Anne-Sophie Karlsson, Margareta Warholm. Phenotyping of cytochrome P450 2E1 in vitro and in vivo. Current drug metabolism. 2007 Jun; 8(5):493-8. doi: 10.2174/138920007780866843. [PMID: 17584020]
  • Sara Asimus, Doaa Elsherbiny, Trinh N Hai, Britt Jansson, Nguyen V Huong, Max G Petzold, Ulrika S H Simonsson, Michael Ashton. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. Fundamental & clinical pharmacology. 2007 Jun; 21(3):307-16. doi: 10.1111/j.1472-8206.2007.00471.x. [PMID: 17521300]
  • E K Kuffner, J L Green, G M Bogdan, P C Knox, R B Palmer, K Heard, J T Slattery, R C Dart. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC medicine. 2007 May; 5(?):13. doi: 10.1186/1741-7015-5-13. [PMID: 17537264]
  • Jason R Catania, Barbara P McGarrigle, Kate Rittenhouse-Olson, James R Olson. Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium. Toxicology in vitro : an international journal published in association with BIBRA. 2007 Feb; 21(1):109-15. doi: 10.1016/j.tiv.2006.08.001. [PMID: 17011741]
  • Nantaporn Prompila, Supeecha Wittayalertpanya, Piyawat Komolmit. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2007 Jan; 90(1):160-6. doi: . [PMID: 17621748]
  • Phisit Khemawoot, Koichi Yokogawa, Tsutomu Shimada, Ken-Ichi Miyamoto. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats. Biochemical pharmacology. 2007 Jan; 73(1):155-62. doi: 10.1016/j.bcp.2006.09.006. [PMID: 17049493]
  • Nuntiya Somparn, Upa Kukongviriyapan, Wichittra Tassaneeyakul, Arunee Jetsrisuparb, Veerapol Kukongviriyapan. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. European journal of clinical pharmacology. 2007 Jan; 63(1):43-50. doi: 10.1007/s00228-006-0224-x. [PMID: 17119944]
  • Yu Chul Kim, Inchul Lee, Sang Geon Kim, Seong-Hee Ko, Myung Gull Lee, So Hee Kim. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h. Life sciences. 2006 Nov; 79(23):2179-86. doi: 10.1016/j.lfs.2006.07.016. [PMID: 16914164]
  • Hye W Baek, Soo K Bae, Myung G Lee, Young T Sohn. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation. Journal of pharmaceutical sciences. 2006 Nov; 95(11):2452-62. doi: 10.1002/jps.20698. [PMID: 16886191]
  • Valérie Wauthier, Véronique Schenten, Roger K Verbeeck, Pedro Buc Calderon. Ageing is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats. Life sciences. 2006 Oct; 79(20):1913-20. doi: 10.1016/j.lfs.2006.06.046. [PMID: 16904701]
  • Reginald F Frye, Nathalie K Zgheib, Gary R Matzke, Diego Chaves-Gnecco, Mordechai Rabinovitz, Obaid S Shaikh, Robert A Branch. Liver disease selectively modulates cytochrome P450--mediated metabolism. Clinical pharmacology and therapeutics. 2006 Sep; 80(3):235-45. doi: 10.1016/j.clpt.2006.05.006. [PMID: 16952490]
  • Nathalie K Zgheib, Reginald F Frye, Timothy S Tracy, Marjorie Romkes, Robert A Branch. Validation of incorporating flurbiprofen into the Pittsburgh cocktail. Clinical pharmacology and therapeutics. 2006 Sep; 80(3):257-63. doi: 10.1016/j.clpt.2006.06.005. [PMID: 16952492]